The Ratio of CD226 and TIGIT Expression in Tfh and PD-1⁺ICOS⁺Tfh Cells Are Potential Biomarkers for Chronic Antibody-Mediated Rejection in Kidney Transplantation

Figure 2

The percentage and absolute number of different Tfh phenotypes in the CAMR, IgAN, and stable groups. Percentages of (a) Tfh cells, (b) PD-1⁺ICOS⁺Tfh cells, (c) CD226⁺Tfh cells, and (d) TIGIT⁺Tfh cells. Absolute number of (e) Tfh cells, (f) PD-1⁺ICOS⁺Tfh cells, (g) CD226⁺Tfh cells, and (h) TIGIT⁺Tfh cells. (i) The ratio of CD226⁺Tfh cells to TIGIT⁺Tfh cells.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)